GLP-1 weight loss in the UK
GLP-1 receptor agonists like semaglutide (Wegovy) and tirzepatide (Mounjaro) are prescribed for weight management in the UK through the NHS, private clinics, and regulated online services. They can be effective, but long-term maintenance is where the real challenge lies.
Why this matters
GLP-1 medicines have become one of the most discussed topics in UK healthcare. Demand is high, supply has been constrained, and the conversation has largely focused on access and early results. But for people already on treatment, the question shifts: what comes next?
The UK context matters because access routes (NHS vs private), regulatory landscape (MHRA), and prescribing patterns differ from other markets. Understanding the UK picture helps set realistic expectations.
Access routes in the UK
NHS
NICE has approved certain GLP-1 medicines for weight management in the NHS, subject to eligibility criteria (typically BMI thresholds and related conditions). Availability may vary by region and funding decisions.
Private prescribing
Private clinics and regulated online services can prescribe GLP-1 medicines for weight management. Costs vary. It's important to use a service that is registered with the CQC (Care Quality Commission) and that prescribers are appropriately qualified.
Employer and insurer pathways
Some UK employers and health insurers are beginning to fund GLP-1 treatment as part of employee health benefits. These pathways often need oversight of maintenance and outcomes — which is where tools like Healthcount can help.
What maintenance looks like
After the initial months of weight loss, the experience often changes. Appetite suppression may not be as strong. Results slow. Motivation can fade. These are normal patterns, not signs of failure.
Maintenance means staying consistent with medication, noticing early signs of drift, and having support that doesn't add burden. It's the phase where most people need the most help — and often get the least.
How Healthcount helps
Healthcount is quiet-by-design. It's a sat-nav for GLP-1 maintenance: it stays quiet when things look stable, and it nudges you when signals suggest drift. It uses low-burden signals and doesn't require daily food logging.
Healthcount does not prescribe, diagnose, or advise dose changes. It supports maintenance and signposts you to clinical support when needed.
Frequently asked questions
Supporting GLP-1 maintenance in the UK
If you're an insurer or employer, contact us about a pilot.